These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31212861)

  • 1. Aberrant MicroRNA Expression and Its Implications for Uveal Melanoma Metastasis.
    Smit KN; Chang J; Derks K; Vaarwater J; Brands T; Verdijk RM; Wiemer EAC; Mensink HW; Pothof J; de Klein A; Kilic E
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
    Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
    Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.
    Venkatesan N; Kanwar J; Deepa PR; Khetan V; Crowley TM; Raguraman R; Sugneswari G; Rishi P; Natarajan V; Biswas J; Krishnakumar S
    PLoS One; 2016; 11(1):e0146128. PubMed ID: 26812476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in microRNA expression associated with metastasis and survival in patients with uveal melanoma.
    Vashishtha A; Lee TJ; Sharma A; Wallbillich JJ
    Oncotarget; 2020 Apr; 11(16):1435-1447. PubMed ID: 32363001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma.
    Triozzi PL; Achberger S; Aldrich W; Crabb JW; Saunthararajah Y; Singh AD
    Clin Epigenetics; 2016; 8():80. PubMed ID: 27453764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
    Li J; Liu X; Li C; Wang W
    J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 5 microRNA biomarkers associated with the prognosis of uveal melanoma.
    Sun Y; Zhang X; Cong Z; Teng S
    Medicine (Baltimore); 2022 Sep; 101(35):e30366. PubMed ID: 36107591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma.
    Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD
    BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGFβR1, GNAQ, WASL, and RAC1.
    Peng D; Dong J; Zhao Y; Peng X; Tang J; Chen X; Wang L; Hu DN; Reinach PS; Qu J; Yan D
    Cancer Manag Res; 2019; 11():4729-4742. PubMed ID: 31213897
    [No Abstract]   [Full Text] [Related]  

  • 15. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
    Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
    Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression.
    Wróblewska JP; Lach MS; Rucinski M; Piotrowski I; Galus L; Suchorska WM; Kreis S; Marszałek A
    Front Cell Dev Biol; 2022; 10():1008901. PubMed ID: 36619870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and RNA Regulation of Uveal Melanoma.
    Barbagallo C; Stella M; Broggi G; Russo A; Caltabiano R; Ragusa M
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma.
    Dogrusöz M; Ruschel Trasel A; Cao J; Ҫolak S; van Pelt SI; Kroes WGM; Teunisse AFAS; Alsafadi S; van Duinen SG; Luyten GPM; van der Velden PA; Amaro A; Pfeffer U; Jochemsen AG; Jager MJ
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31382494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Next-Generation Sequencing of 117 Routine Clinical Samples Provides Further Insights into the Molecular Landscape of Uveal Melanoma.
    Thornton S; Coupland SE; Olohan L; Sibbring JS; Kenny JG; Hertz-Fowler C; Liu X; Haldenby S; Heimann H; Hussain R; Kipling N; Taktak A; Kalirai H
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32340176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease.
    Neo SY; Oliveira MMS; Tong L; Chen Y; Chen Z; Cismas S; Burduli N; Malmerfelt A; Teo JKH; Lam KP; Alici E; Girnita L; Wagner AK; Westerberg LS; Lundqvist A
    J Exp Clin Cancer Res; 2024 Jan; 43(1):13. PubMed ID: 38191418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.